Drugmaker Sumitomo Pharma America (SMPA) announced it will implement first-time contract pharmacy restrictions next month. The biotech company, which is [...] …
Category: Providers
Japanese drugmaker Astellas will soon extend its limits on 340B pricing to hospitals for its medication to treat overreactive bladder, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drugmakers Amgen and Johnson & Johnson have announced they will provide refunds to 340B providers on past purchases of multiple [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Eighty-five percent of DSH hospitals earned more in estimated 340B revenue in 2022 than they incurred in charity care costs, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
West Virginia provider groups are applauding a newly passed law to bar drugmaker 340B contract pharmacy restrictions in the state [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Significant gaps in hospital and health system’s financial data, including 340B program use, “limit transparency for policymakers, researchers, and consumers,” [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Federal auditors determined terminations from the 340B program were required for either a covered entity site or a contract pharmacy [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A federal judge recently dismissed a large California health system’s whistleblower case against four pharmaceutical companies for alleged fraudulent 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A California ballot initiative aims to codify the California governor’s 2019 shift of the Medicaid program’s prescription drug benefit from [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The 340B program may increase medication costs for self-insured employers, a recent study from a pharmaceutical industry outsourcing and analytics [...] …